Bank Pictet & Cie (Asia) LTD Amgen Inc Transaction History

Bank Pictet & Cie (Asia) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $962,201 - $1.12 Million	-4,336 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $155,144 - $184,749	717 Added 19.81%	4,336 $997,000
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $19,710 - $21,919	-84 Reduced 2.27%	3,619 $920,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $205,920 - $252,692	-1,041 Reduced 21.94%	3,703 $873,000
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $3,973 - $5,107	-21 Reduced 0.44%	4,744 $1.14 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $225,312 - $254,010	-1,216 Reduced 20.33%	4,765 $988,000
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $993,145 - $1.12 Million	5,981 New	5,981 $1.1 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.